Neuren Pharmaceuticals LimitedASX: NEU

DAYBUE (trofinetide) 2024 net sales US$348 million

Feb 27, 2025 at 4:22 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment